Analystreport

Stoke Therapeutics (NASDAQ: STOK) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Stoke Therapeutics, Inc.  (STOK) 
Last stoke therapeutics, inc. earnings: 11/12 08:00 am Check Earnings Report